Avid Bioservices Inc (CDMO)

[jimsgtx]

FWIW Google alert... Peregrine Pharmaceuticals(NASDAQ:PPHM) a biopharmaceutical company, is involved in the research and growth of novel monoclonal antibodies for the cure and diagnosis of cancer in the United States. Its lead immunotherapy candidate, bavituximab, is in Phase III growth for the treatment of second-line non-small cell lung cancer along with a variety of investigator-sponsored trials evaluating other cure combinations and additional oncology indications.

Peregrine Pharmaceuticals (NASDAQ:PPHM) showing jumped of +2.72% and closed at $1.51, after gaining total volume of 1.65 million shares. Its opening price was $1.46. Its earnings per share(EPS) is -$0.27 and its beta value stands at 1.35 points and has total market capitalization of $264.16 billion and a total of 182.08 million outstanding shares.